Skip to content

Clinical trials

Mental Disorders trials in Canada with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mental Disorders Phase: Not applicable Country / region: Canada Clear all

60 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20051
20061
20091
20112
20123
20131
20142
20153
20165
20174
20184
20195
20202
20212
20229
20236
20243
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed30
Unknown status12
Recruiting9
Active, not recruiting6
Terminated1
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Centre for Addiction and Mental Health16
McMaster University4
St. Justine's Hospital3
Ciusss de L'Est de l'Île de Montréal2
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's2
McGill University2
Nova Scotia Health Authority2
Queen's University2
St. Joseph's Healthcare Hamilton2
University Health Network, Toronto2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mental Disorders60
Psychotic Disorders11
Substance-Related Disorders9
Schizophrenia8
Anxiety Disorders7
Bipolar Disorder6
Major Depressive Disorder4
Conduct Disorder3
Mood Disorders3
Neurodevelopmental Disorders3

Trials

Showing 1 to 25 of 60. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.